Lancet Oncology, 22, 29-42 Lancet Oncology, 22(1), 29-42. ELSEVIER SCIENCE INC the RAPIDO collaborative investigators 2021, ' Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial ', The Lancet Oncology, vol. 22, no. 1, pp. 29-42 . https://doi.org/10.1016/S1470-2045(20)30555-6 The Lancet Oncology, 22(1), 29-42. ELSEVIER SCIENCE INC The Lancet. Oncology r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA instname Lancet Oncology, 22, 1, pp. 29-42 The Lancet Oncology, 22(1), 29-42. ELSEVIER The Lancet Oncology, 22(1), 29-42. Lancet Publishing Group lancet oncology, 22(1), 29-42. Lancet Publishing Group
Scientia INTERNATIONAL JOURNAL OF COLORECTAL DISEASE r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe instname Dipòsit Digital de Documents de la UAB Universitat Autònoma de Barcelona International Journal of Colorectal Disease